In this study, the HepG2 cells, in which ID1 is highly expressed, showed more sensitive to sorafenib than Hep3B, we analyzed the changes of ID1 and p‐AKT in the two different HCC cells under the treatment of sorafenib and 5‐aza, by alone or combination. The gene discussed is ID1; the disease is hepatocellular carcinoma.